Yp. Ho et al., SPECTRAL AND CHROMATOGRAPHIC PROPERTIES OF 2-METHOXYPHENYLMETYRAPONE AND ITS POTENTIAL METABOLITES, Journal of pharmaceutical and biomedical analysis, 15(4), 1997, pp. 479-486
In the search for new metyrapone derivatives as radioligands for the f
unctional diagnosis of adrenal pathology, 2-methoxyphenylmetyrapone me
thoxyphenyl)-2-methyl-2-(3-pyridyl)-1-propanone] (1), and related 2-su
bstituted phenylmetyrapone derivatives, have been separated as potent
inhibitors of adrenal 11 beta-hydroxylase, with high affinity for adre
nal mitochondrial binding sites. Surprisingly, 2-[C-11]MPMP showed a r
apid loss of the radioactive label, which prompted investigation of it
s metabolism. Synthetic 2-MPMP (1) and its seven potential metabolites
(2-8) have been identified spectroscopically (H-1- and C-13-NMR and m
ass spectrometry) and further characterised by chromatography (TLC and
gradient reversed-phase HPLC). Chromatographic and mass analysis of u
rinary extracts from rats dosed with 2-MPMP have confirmed the major m
etabolites as 2-hydroxyphenylmetyrapone(2-OHPMP), 2) and its N-oxide (
2-OHPMP-NO, 6), which are present predominantly as conjugates.